Union Health Minister says first Covid vaccine dose given to 86 per cent of eligible population

Sharing data about the COVID vaccination levels in other countries, including the US, Germany and France, Mansukh Mandaviya said that India has been doing well on the vaccination front.

Published: 10th December 2021 01:32 PM  |   Last Updated: 10th December 2021 01:32 PM   |  A+A-

A man closes his eyes as he receives a Covishield vaccine for COVID-19 at a Primary Health Centre in Dharmsala.

A man closes his eyes as he receives a Covishield vaccine for COVID-19 at a Primary Health Centre in Dharmsala. (Photo | AP)

By PTI

NEW DEHI: As many as 86 per cent of India's eligible population has received the first dose of COVID vaccine and the government wishes that 100 per cent vaccination is achieved at the earliest, Union Health Minister Mansukh Mandaviya said on Friday.

Sharing data about the COVID vaccination levels in other countries, including the US, Germany and France, the minister said that India has been doing well on the vaccination front.

Replying to supplementary questions in the Lok Sabha, Mandaviya also said that 7 crore vaccines are lying with states and also cautioned against possible vaccine hesistancy that could be triggered by claims of health complications after vaccination.

ALSO READ | Centre ask states to review vaccine requirement as Serum Institute looks at cutting down production of Covishield

During the question hour, he said that 86 per cent of the eligible population has received the first COVID dose and "we wish that 100 per cent vaccination happens at the earliest".

To a query related to Omicron, he said that studies are going on and only after the studies are complete, it will be known which vaccine is how much effective against the new variant.

Currently, 23 cases of Omicron have been reported in the country while worldwide, a total of 59 countries have reported such cases.

There are 36 laboratories for genome sequencing in the country now.

ALSO READ | Omicron infection depends on immunity level, not vaccine taken

These laboratories can do 30,000 genome sequencing and the capacity is being increased with the help of private laboratories, Mandaviya said.

In a written reply, he said the National Technical Advisory Group on Immunization (NTAGI) and National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) are deliberating and considering scientific evidences related to dose schedule of vaccines and the need for justification for booster dose.

As on December 6, "about 80.02 crore eligible beneficiaries (85.2 per cent) (i.e. persons aged 18 years & above) have received at least one dose of COVID-19 vaccine and 47. 91 crore (51.0 per cent) have received both the doses of the vaccine", he added.

The COVID vaccination drive started in January this year.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp